Valencia Industrial Dialogue on Precision Medicine - Ana Sabater
Channel: SMART-map Project
Date: 25/09/2017

“Pharmacogenetics is studying the biomarkers to know if a medicine will be giving a correct result for a patient: the final goal is to prescribe the correct medicine to each patient according to its genes and at the correct dose.” Ana Sabater, who works at Eugenomic, explains the important role that this discipline could have in managing statins side effects.

More at http://projectsmartmap.eu/precision-medicine/

________________________________________________________________________________________________

SMART-map (RoadMAPs to Societal Mobilisation for the Advancement of Responsible Industrial Technologies) is a coordination and support action financed by the European Commission under the Horizon 2020 Programme (Grant Agreement no. 710500)

Its goal is to define and implement concrete roadmaps for the responsible development of technologies and services in three fields: precision medicine, synthetic biology and 3D printing in biomedicine.

Learn more at http://projectsmartmap.eu/

LinkedIn group: https://www.linkedin.com/groups/11900187
Twitter: @eusmartmap
Facebook: https://www.facebook.com/eusmartmap